Four polymorphisms of the MLL3 gene (rs6943984, rs4725443, rs3800836, rs6464211) were genotyped using the TaqMan method in 592 patients with larynx cancer and 602 age‐ and sex‐matched noncancer controls. This evidence concerns the gene KMT2C and laryngeal neoplasm.